Skip to content
Trial Eligibility
Menu

Decision Counseling and Follow-up for Shield+ Patients

NCT07620535

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Colo-rectal Cancer

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
45 to 75 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Guardant Health, Inc.
Last updated on ClinicalTrials.gov
November 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • Jefferson Center · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.